You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-C-JUN (JUN) Antibodies

Full name:
anti-Jun Proto-Oncogene Antibodies (JUN)
On are 868 Jun Proto-Oncogene (JUN) Antibodies from 33 different suppliers available. Additionally we are shipping C-JUN Kits (81) and C-JUN Proteins (24) and many more products for this protein. A total of 1034 C-JUN products are currently listed.
AP-1, AP1, B230310J22Rik, Bsk, BSK/DJNK, c-jun, CG2275, CG5680, cJun, D-JNK, d-JRA, d-jun, D-jun/Jra, D-junk, dAP-1, DBSK/JNK, dJNK, DJNK/bsk, dJra, djun, dm-Jun, Dmel\\CG2275, Dmel\\CG5680, fj36h07, jnk, JNK/SAPK, jra, jun, Junc, Junk, l(2)46Ef, l(2)IA109, l(2R)IA109, p39, SAPKa, V, wu:fj36h07, zgc:65863

All available anti-C-JUN Antibodies

Go to our pre-filtered search.

Top referenced anti-C-JUN Antibodies

  1. Human Polyclonal C-JUN Primary Antibody for IHC, ELISA - ABIN1531887 : Binétruy, Smeal, Karin: Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. in Nature 1991 (PubMed)
    Show all 4 references for ABIN1531887

  2. Human Polyclonal C-JUN Primary Antibody for ELISA, WB - ABIN1531890 : Smeal, Binetruy, Mercola, Birrer, Karin: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. in Nature 1992 (PubMed)
    Show all 4 references for ABIN1531890

  3. Human Polyclonal C-JUN Primary Antibody for IHC, ELISA - ABIN1531886 : Dérijard, Hibi, Wu, Barrett, Su, Deng, Karin, Davis: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. in Cell 1994 (PubMed)
    Show all 4 references for ABIN1531886

  4. Human Polyclonal C-JUN Primary Antibody for IHC, ELISA - ABIN1531889 : Kyriakis, Banerjee, Nikolakaki, Dai, Rubie, Ahmad, Avruch, Woodgett: The stress-activated protein kinase subfamily of c-Jun kinases. in Nature 1994 (PubMed)
    Show all 4 references for ABIN1531889

  5. Human Polyclonal C-JUN Primary Antibody for DB - ABIN389696 : Fang, Kerppola: Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. in Proceedings of the National Academy of Sciences of the United States of America 2004 (PubMed)
    Show all 2 references for ABIN389696

  6. Human Polyclonal C-JUN Primary Antibody for DB, IHC (p) - ABIN389544 : Wang, Li, Qi, Yuan, Ai, Zhu, Cao, Yang, Liu, Wu, Liu: TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. in Biochemical and biophysical research communications 2004 (PubMed)
    Show all 2 references for ABIN389544

  7. Human Polyclonal C-JUN Primary Antibody for FACS, IHC (p) - ABIN650689 : Song, Han, Sabapathy, Lee, Yu, Choi: Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation. in The Journal of biological chemistry 2010 (PubMed)
    Show all 2 references for ABIN650689

  8. Chicken Polyclonal C-JUN Primary Antibody for WB - ABIN2780412 : Adiseshaiah, Li, Vaz, Kalvakolanu, Reddy: ERK signaling regulates tumor promoter induced c-Jun recruitment at the Fra-1 promoter. in Biochemical and biophysical research communications 2008 (PubMed)

More Antibodies against C-JUN Interaction Partners

Xenopus laevis Jun Proto-Oncogene (JUN) interaction partners

  1. AP-1(c-Jun/FosB (show FOSB Antibodies)) may play a role in neurogenesis via the induction of FoxD5b expression during early vertebrate development

  2. The cJun transcription factor bound to a variant cAMP response element in the promoter region of tlx3 (show TLX3 Antibodies) and modulated transcription and regulated neurotransmitter phenotype via its transactivation domain

Fruit Fly (Drosophila melanogaster) Jun Proto-Oncogene (JUN) interaction partners

  1. malignant transformation of the ras(V12)scrib(1 (show SCRIB Antibodies)) tumors requires bZIP protein Fos, the ETS (show ETS1 Antibodies)-domain factor Ets21c and the nuclear receptor Ftz-F1 (show NR5A2 Antibodies), all acting downstream of Jun-N-terminal kinase (show MAPK8 Antibodies).

  2. Diminished MTORC1-dependent JNK (show MAPK8 Antibodies) activation underlies the neurodevelopmental defects associated with lysosomal dysfunction.

  3. ROS (show ROS1 Antibodies)/JNK (show MAPK8 Antibodies)/p38 (show MAPK14 Antibodies)/Upd (show UROD Antibodies) stress responsive module restores tissue homeostasis. This module is not only activated after cell death induction but also after physical damage and reveals one of the earliest responses for imaginal disc regeneration.

  4. Significantly, the JNK (show MAPK8 Antibodies) pathway is responsible for the majority of the phenotypes and transcriptional changes downstream of Notch (show NOTCH1 Antibodies)-Src (show SRC Antibodies) synergy.

  5. This study demonstrated that the mechanism by which Bsk (show FRK Antibodies) is required for pruning is through reducing the membrane levels of the adhesion molecule (show NCAM1 Antibodies) Fasciclin II (show NCAM2 Antibodies) (FasII)

  6. Jra recruits the HP1a (show CBX5 Antibodies)/KDM4A (show KDM4A Antibodies) complex to its gene body region upon osmotic stress to reduce H3K36 methylation levels and disrupt H3K36 methylation-dependent histone deacetylation

  7. Study solves the crystal structure of unphosphorylated DJNK in complex with adenylyl imidodiphosphate (AMP (show AMPH Antibodies)-PNP (show NP Antibodies)) and magnesium.

  8. PERK/ATF4 activated the JNK pathway through Rac1 and Slpr activation in apoptotic cells.

  9. Data show that oxidative stress and neuroinflammation are intrinsic components of TDP-43 (show TARDBP Antibodies)-associated neurodegeneration and the balance between cytoprotective JNK (show MAPK8 Antibodies) and cytotoxic p38 (show MAPK14 Antibodies) signaling dictates phenotypic outcome to TDP-43 (show TARDBP Antibodies) expression in Drosophila.

  10. Data show that the actin-Capping Protein (show TMOD4 Antibodies) (CP) alphabeta heterodimer, which regulates actin (show ACTB Antibodies) filament (F-actin (show ACTB Antibodies)) polymerization, limits Src (show SRC Antibodies)-induced apoptosis or tissue overgrowth by restricting JNK (show MAPK8 Antibodies) activation.

Pig (Porcine) Jun Proto-Oncogene (JUN) interaction partners

  1. The effects of prostaglandin F2alpha administration on transcription factor AP-1 expression and the expression of downstream genes involved in luteolysis are reported.

Rabbit Jun Proto-Oncogene (JUN) interaction partners

  1. ICAM1 (show ICAM1 Antibodies) and IL10 (show IL10 Antibodies) were upregulated in ventilator-induced lung injury. Nuclear transcription factor AP-1 may be responsible for this upregulation.

Mouse (Murine) Jun Proto-Oncogene (JUN) interaction partners

  1. this study shows that c-Jun regulates the activation state of macrophages and promotes arthritis via differentially regulating cyclooxygenase-2 (show PTGS2 Antibodies) and arginase-1 (show ARG1 Antibodies) levels

  2. PLIO treatment inhibited nuclear factorkappaB (NFkappaB) nuclear translocation in B16F10 cells. In addition, PLIO treatment inhibited the phosphorylation of c-Jun Nterminal kinases and AKT (show AKT1 Antibodies)

  3. Anxa5 (show ANXA5 Antibodies) mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells via ERK2 (show MAPK1 Antibodies)/c-Jun/p-c-Jun(Ser73) and ERK2 (show MAPK1 Antibodies)/E-cadherin (show CDH1 Antibodies) pathways.

  4. These findings indicate that c-Jun has important functions during HBV-associated tumorigenesis by promoting hepatocyte proliferation as well as progression of dysplasia

  5. The TLR4 (show TLR4 Antibodies) pathway may play an important role in regulating AP-1 activation

  6. These observations suggest that the antiinflammatory properties of crebanine may stem from the inhibition of proinflammatory mediators via suppression of the NF-kappaB (show NFKB1 Antibodies), AP-1, MAPKs, and Akt (show AKT1 Antibodies) signaling pathways.

  7. In a model of heavy metal poisoning, copper contamination of drinking water (as can occur with corrosion in aging plumbing systems) up-regulates binding of transcription factor AP-1 in neurons of brain, even in low concentrations.

  8. Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-kappaB (show NFKB1 Antibodies) and AP-1 to the major immediate early promoter.

  9. These data suggest p35 (show CDK5R1 Antibodies) and p39 (show ATP6V0D1 Antibodies) have specific and overlapping roles in oligodendrocyte development, some of which may be independent of Cdk5 (show CDK5 Antibodies) activation.

  10. ERK (show EPHB2 Antibodies) contributes to the morphine-induced hyperalgesia by regulating the activation of c-JUN

Human Jun Proto-Oncogene (JUN) interaction partners

  1. Suggest UCA1 and C-JUN mRNA as promising diagnostic and prognostic markers in hepatocellular carcinoma.

  2. During inflammatory conditions, AP-1 (show FOSB Antibodies) and Sp1 (show PSG1 Antibodies) sustained the expression of ADAMTS7 (show ADAMTS7 Antibodies), and ADAMTS7 (show ADAMTS7 Antibodies) sustained the expression of catabolic genes in nucleus pulposus cells

  3. our data strongly suggest that AQCA-mediated suppression of inflammatory responses could be managed by a direct interference of signaling cascades including IRAK (show IRAK1 Antibodies) and Syk (show SYK Antibodies), linked to the activation of NF-kappaB (show NFKB1 Antibodies) and AP-1 (show FOSB Antibodies).

  4. p-c-Jun may act as a biomarker for predicting responses of sorafenib treatment, thus advocating targeting of JNK/c-Jun signaling as an optimal therapeutic strategy in a subset of hepatocellular carcinoma (HCC (show FAM126A Antibodies))

  5. Necrotic cells induced NF-kappaB (show NFKB1 Antibodies) and AP-1 (show FOSB Antibodies) activation and their binding to the IL-8 (show IL8 Antibodies) promoter, leading to enhanced IL-8 (show IL8 Antibodies) production and secretion in glioblastoma multiforme cells.

  6. RYBP activates FANK1-mediated activator protein 1 (AP-1) signaling pathway which contributes to tumor cell apoptosis.

  7. The study aimed to identify a small set of genetic signatures that may reliably predict the individuals with a high genetic propensity to heroin addiction. A set of 4 genes (JUN, CEBPB (show CEBPB Antibodies), PRKCB (show PRKCB Antibodies), ENO2 (show ENO2 Antibodies), or CEBPG (show CEBPG Antibodies)) could predict the diagnosis of heroin addiction with the accuracy rate around 85% in our dataset.

  8. We found that c-jun or c-fos was significantly associated with lymph node metastasis, and coexpression of c-jun/c-fos, or c-jun/c-fos/p53 (show TP53 Antibodies) were significantly associated with lymph node metastasis, poor differentiation and clinical stage.

  9. data suggest that the GRP94 (show HSP90B1 Antibodies)/CCT8 (show CCT8 Antibodies)/c-Jun/EMT (show ITK Antibodies) signaling cascade might be a new therapeutic target for HCC (show FAM126A Antibodies)

  10. inhibition of SH3GL1 (show SH3GL1 Antibodies) reverses multidrug resistance through declining P-glycoprotein expression via the EGFR (show EGFR Antibodies)/ERK (show EPHB2 Antibodies)/AP-1 (show FOSB Antibodies) pathway.

Zebrafish Jun Proto-Oncogene (JUN) interaction partners

  1. These results support a role for trim69 (show TRIM69 Antibodies) in the development of the zebrafish brain through ap-1 pathway.

  2. CPEB-1 (show CPEB1 Antibodies) control of c-Jun mRNA translation regulates GH gene expression and resulting downstream signaling events (e.g., synaptic plasticity) in the mouse hippocampus.

Cow (Bovine) Jun Proto-Oncogene (JUN) interaction partners

  1. The present data indicate that bovine dialyzable leukocyte extract can block the AP-1 DNA-binding activity and expression of several transcriptions factors in breast cancer cells.

  2. dynamic compression stimulates cell proliferation and proteoglycan (show Vcan Antibodies) synthesis in the presence of IL-1beta (show IL1B Antibodies) and/or inhibitors of the MAPKs and NFkappaB and AP-1 signalling pathways

C-JUN (JUN) Antigen Profile

Antigen Summary

This gene is the putative transforming gene of avian sarcoma virus 17. It encodes a protein which is highly similar to the viral protein, and which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies.

Alternative names and synonyms associated with C-JUN (JUN)

  • jun oncogene (jun) antibody
  • basket (bsk) antibody
  • C-JUN protein (C-JUN) antibody
  • c-Jun protein (C-JUN) antibody
  • c-jun transcription factor (C-JUN) antibody
  • cyclin-dependent kinase 5, regulatory subunit 2 (p39) (Cdk5r2) antibody
  • Jun oncogene (Jun) antibody
  • jun proto-oncogene (JUN) antibody
  • jun proto-oncogene (jun) antibody
  • jun proto-oncogene (Jun) antibody
  • Jun-related antigen (Jra) antibody
  • AP-1 antibody
  • AP1 antibody
  • B230310J22Rik antibody
  • Bsk antibody
  • BSK/DJNK antibody
  • c-jun antibody
  • CG2275 antibody
  • CG5680 antibody
  • cJun antibody
  • D-JNK antibody
  • d-JRA antibody
  • d-jun antibody
  • D-jun/Jra antibody
  • D-junk antibody
  • dAP-1 antibody
  • DBSK/JNK antibody
  • dJNK antibody
  • DJNK/bsk antibody
  • dJra antibody
  • djun antibody
  • dm-Jun antibody
  • Dmel\\CG2275 antibody
  • Dmel\\CG5680 antibody
  • fj36h07 antibody
  • jnk antibody
  • JNK/SAPK antibody
  • jra antibody
  • jun antibody
  • Junc antibody
  • Junk antibody
  • l(2)46Ef antibody
  • l(2)IA109 antibody
  • l(2R)IA109 antibody
  • p39 antibody
  • SAPKa antibody
  • V antibody
  • wu:fj36h07 antibody
  • zgc:65863 antibody

Protein level used designations for JUN

v-jun sarcoma virus 17 oncogene homolog , CG5680-PB , CG5680-PE , CG5680-PF , JNK , JUN kinase , Jun N-terminal kinase , Jun NH2-terminal kinase , Jun-N-terminal kinase , Jun-kinase , bsk-PB , bsk-PE , bsk-PF , c-Jun N-terminal kinase , c-Jun aminoterminal kinase , c-Jun-N-terminal kinase , drosophila JNK , AP1 , V-jun avian sarcoma virus 17 oncogene homolog , activator protein 1 , proto-oncogene c-jun , transcription factor AP-1 , CDK5 activator 2 , cyclin-dependent kinase 5 activator 2 , cyclin-dependent kinase 5 regulatory subunit 2 , p39I , AH119 , immediate early , jun A , Jun activation domain binding protein , enhancer-binding protein AP1 , jun oncogene , p39 , proto-oncogene c-Jun , v-jun avian sarcoma virus 17 oncogene homolog , Avian sarcoma virus 17 (v-jun) oncogene homolog , Jun oncogene , v-jun sarcoma virus 17 oncogene , CG2275-PA , CG2275-PB , CG2275-PC , Jra-PA , Jra-PB , Jra-PC , Jun related antigen , complementation group V , lethal(2)1A109 , lethal(2)IA109

379050 Xenopus laevis
44801 Drosophila melanogaster
396913 Sus scrofa
443219 Ovis aries
100008856 Oryctolagus cuniculus
12570 Mus musculus
16476 Mus musculus
3725 Homo sapiens
335916 Danio rerio
24516 Rattus norvegicus
399400 Xenopus laevis
424673 Gallus gallus
609429 Canis lupus familiaris
280831 Bos taurus
100170668 Ovis aries
36057 Drosophila melanogaster
Selected quality suppliers for anti-C-JUN (JUN) Antibodies
Did you look for something else?